(Date:5/15/2008)...cellent results obtained with a newly cleared devi...laques of interest that are associated with ...URLINGTON, Mass., May 15 /- InfraReDx... Hospital in Royal Oak, Mich., have,successfully u...patient,undergoing a cardiac catheterization. This...
(Date:5/15/2008)...OSTON, May 15 /- CenterWatch, a publi...market research about clinical,trials, finds that ... EDC,(electronic data capture) systems. More than ...indicated that they had been trained on three or m... that the effectiveness of,their EDC training had ...
(Date:5/15/2008)...derable Opportunity Remains for an Antiplatelet Th...eeding than the Combination of Plavix/Iscover ...on Resources, WALTHAM, Mass., May 15 /PRNewswire/... research and advisory firms for pharmaceutical an... Lilly,s Effient offers,improvement in patient com...
(Date:5/15/2008)...andomized TRIAS HR Pilot Study Compares Genous, Bo...axus(R), Other Presentations Focus on Real-World U...h AMI, Those Who Could Not Tolerate Dual-Antiplate...LONA, Spain, May 15 /- OrbusNeich tod...ions in a symposium at EuroPCR 2008,support the us...
Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Experimental Drug Fails Against Heart Failure 5670 1Experimental Drug Fails Against Heart Failure 5670 2Experimental Drug Fails Against Heart Failure 5670 3Unlocking the function of enzymes 1130 1Unlocking the function of enzymes 1130 2AcroMetrix Announces Launch of PeliSpy Chagas Positive Control 5665 1Health Care Tops Issues Voters in Early Primary States Want 2008 Presidential Candidates to Address 5662 1Health Care Tops Issues Voters in Early Primary States Want 2008 Presidential Candidates to Address 5662 2... BOSTON, April 25, 2007 /PRNewswire-USNewswire/ -...bipolar disorder first,appear in childhood or adol... to distinguish bipolar symptoms from those of oth...ard Mental Health,Letter. , Children, especially y... of distinct mood episodes of mania and depression...
... LANGENFELD, Germany, April 25, 2007-Labtec GmbH ...ompany announces positive,results from a multiple ...il transdermal patch. , “Today, we are pleas...cond clinical trial for our Sufentanil,TDS®. O...y in,the first half of 2007,” says Dr. Armin...
Other Medicine Technology:Bipolar Disorder in Children Difficult to Diagnose, Reports the,Harvard Mental Health Letter 2Labtec’s Next Generation Pain Patch Successful in Clinical,Studies 2(Date:5/16/2008)...ocs determine who would benefit most from chemo af...16 (HealthDay News) -- A panel of 15 genes may hel...all cell lung cancer will experience a recurrence ..., a new study shows. , By extension, the same ...less aggressive forms of the cancer who would be a...
(Date:5/16/2008)...ON, May 16 /PRNewswire-USNewswire/ -- As tropical ... Irrawaddy delta, survivors of,Cyclone Nargis are ...Many,survivors still need assistance, as exposure ...an increasingly dire situation., "The people livi...recover from this disaster and get back on their f...
(Date:5/16/2008)... Funding Per Death Drops More in 2007, WASHINGTON...cer causes,one in three cancer deaths, the Nationa...its $4.8 billion budget in lung cancer research in...ung Cancer Alliance (LCA) today., The two other f...rograms -- Centers for Disease Control and Prevent...
(Date:5/16/2008)...O, May 16 /PRNewswire-FirstCall/ -- CryoCor, Inc. ...n the treatment of cardiac,arrhythmias, announced ...CryoCor common stock filed a complaint in the Supe...an Diego, naming as defendants each member of the,...Scientific Corporation.,The complaint is styled Se...
Breaking Medicine News(10 mins):Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4...tial to protect the kidneys from failing after inj...mice were genetically engineered to express higher...c growth factor (HGF) or another natural factor ca...in (PTHrP). Both groups of mice developed normal k...
...cted SARS case in six months may have the coronavi...was waiting for more results to come in.// "There...cted the SARS coronavirus," Xu Ruiheng, deputy dir...ses prevention and control, said on Hong Kong cabl...
...y combat death, heart attack and repeat procedures...ffects of drug-coated stents on patients.// The s...ly untreated blocked arteries who were treated wit...450 patients with comparable blockages were treate...
...nce it interferes with eating and drinking. Childr...y do not realize the importance of maintaining// t...y reveals that a tonsillectomy procedure using les...y be the key to reducing pain during recovery.<...
Other Medicine News:Health News:New Hope for Kidney Failure 2Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes
Sera available in three levels for the control of accuracy and precision for up to 31 analytes
Human based material available in two levels for thecontrol of percision for up to 10 analytes
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes.
Medicine Products: